Want to see HK:1518 full AI Analyst Report?
1518 Stock Chart & Stats
HK$0.24
HK$0.01(3.13%)
At close: 4:00 PM EDT
HK$0.24
HK$0.01(3.13%)
Day’s Range― - ―
52-Week RangeHK$0.07 - HK$0.85
Previous CloseN/A
Volume500.00
Average Volume (3M)9.38K
Market Cap
HK$111.29M
Enterprise Value-HK$45.08
Total Cash (Recent Filing)HK$278.97M
Total Debt (Recent Filing)HK$164.05M
Price to Earnings (P/E)―
Beta0.43
Next Earnings
Apr 01, 2027EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend Yield9.69%
Share Statistics
EPS (TTM)-0.28
Shares Outstanding490,025,000
10 Day Avg. Volume850
30 Day Avg. Volume9,383
Financial Highlights & Ratios
PEG Ratio<0.01
Price to Book (P/B)0.67
Price to Sales (P/S)0.48
P/FCF Ratio34.57
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)N/A
Revenue Forecast (FY)N/A
Bulls Say, Bears Say
Bulls Say
Manageable Leverage And Positive EquityModerate leverage and positive equity provide a meaningful financial cushion for the healthcare services business. This supports continued operations and preserves some flexibility to fund facilities and services, although that strength could weaken if losses persist or returns remain negative.
Free Cash Flow Remained PositivePositive free cash flow in a loss-making year indicates the company still generated some cash after investment needs, rather than relying entirely on external funding. That provides a foundation for near-term resilience, even though the sharp decline shows cash generation is not yet dependable.
Demonstrated Prior ProfitabilityThe strong 2023–2024 operating period demonstrates that the healthcare platform has previously converted activity into operating profit and net income. This suggests an earnings recovery is possible if revenue and margins stabilize, giving the business an established profitability precedent.
Bears Say
Revenue Contraction And Return To LossesThe sharp 2025 revenue decline and return to negative operating profit weaken confidence in the durability of the company’s earnings base. Continued contraction would reduce operating leverage, limit reinvestment capacity, and make a sustained recovery in shareholder returns more difficult.
Severe Deterioration In Cash ConversionThe steep reduction in free cash flow materially lowers financial flexibility compared with 2023–2024. Weak operating cash coverage of the net loss also signals that reported performance is not translating into cash efficiently, increasing dependence on balance-sheet resources if weakness continues.
Volatile Profitability And Margin CompressionRepeated loss years and the 2025 gross-margin compression show that profitability has not been consistently sustained across the business cycle. Weaker pricing, mix, or higher costs can reduce the benefit of revenue recovery and make future earnings more sensitive to operating execution.
New Century Healthcare Holding Co. Ltd. News
1518 FAQ
What was New Century Healthcare Holding Co. Ltd.’s price range in the past 12 months?
New Century Healthcare Holding Co. Ltd. lowest stock price was HK$0.07 and its highest was HK$0.85 in the past 12 months.
What is New Century Healthcare Holding Co. Ltd.’s market cap?
New Century Healthcare Holding Co. Ltd.’s market cap is HK$111.29M.
When is New Century Healthcare Holding Co. Ltd.’s upcoming earnings report date?
New Century Healthcare Holding Co. Ltd.’s upcoming earnings report date is Apr 01, 2027 which is in 189 days.
How were New Century Healthcare Holding Co. Ltd.’s earnings last quarter?
New Century Healthcare Holding Co. Ltd. released its earnings results on Aug 31, 2026. The company reported -HK$0.2 earnings per share for the quarter.
Is New Century Healthcare Holding Co. Ltd. overvalued?
According to Wall Street analysts New Century Healthcare Holding Co. Ltd.’s price is currently Overvalued.
Does New Century Healthcare Holding Co. Ltd. pay dividends?
New Century Healthcare Holding Co. Ltd. pays a Annually dividend of HK$0.022 which represents an annual dividend yield of 9.69%. See more information on New Century Healthcare Holding Co. Ltd. dividends here
What is New Century Healthcare Holding Co. Ltd.’s EPS estimate?
New Century Healthcare Holding Co. Ltd.’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does New Century Healthcare Holding Co. Ltd. have?
New Century Healthcare Holding Co. Ltd. has 490,025,000 shares outstanding.
What happened to New Century Healthcare Holding Co. Ltd.’s price movement after its last earnings report?
New Century Healthcare Holding Co. Ltd. reported an EPS of -HK$0.2 in its last earnings report. Following the earnings report the stock price went same 0%.
Which hedge fund is a major shareholder of New Century Healthcare Holding Co. Ltd.?
Currently, no hedge funds are holding shares in HK:1518
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Company Description
New Century Healthcare Holding Co. Ltd.
New Century Healthcare Holding Co. Limited functions as an investment enterprise, providing medical services specifically designed for women and children throughout the People's Republic of China. Its principal activities include specialized care in paediatrics, obstetrics, and gynaecology, complemented by hospital advisory services. Furthermore, the company offers digital healthcare solutions and operates on-site amenities like cafeterias and gift shops within its medical facilities. This entity was founded in 2002 and maintains its headquarters in Beijing, China.
Technical Analysis
Human Health Holdings Ltd.
―
Guangdong Kanghua Healthcare Co., Ltd. Class H
―
Hospital Corporation of China Ltd
―
Town Health International Medical Group Ltd.
―
UMP Healthcare Holdings Limited
―